Table 3. The relative distribution and prevalence of cancer cases by type in the All of Us Research Program from self-reported survey data and electronic medical record by race/ethnicity.
| NH-White | African American/Black | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EHR | Survey data | EHR + Survey | EHR | Survey data | EHR + survey | |||||||||||||
| N | % dist | prevalence | N | % dist | prevalence | N | % dist | prevalence | N | % dist | prevalence | N | % dist | prevalence | N | % dist | prevalence | |
| Population | 105,678 | 67,991 | 47,345 | 41,515 | 6,746 | 4,971 | ||||||||||||
| Total Cancer | 15,776 | - | 14.9% | 11,276 | - | 16.6% | 6,125 | - | 12.9% | 3,361 | - | 8.1% | 669 | - | 9.9% | 328 | - | 6.6% |
| Bladder | 783 | 4.96% | 0.74% | 440 | 3.90% | 0.65% | 279 | 4.56% | 0.59% | 84 | 2.5% | 0.20% | ~ | NA | ~ | ~ | NA | ~ |
| Blood | 3,136 | 19.88% | 2.97% | 983 | 8.72% | 1.45% | 583 | 9.52% | 1.23% | 730 | 21.7% | 1.76% | 30 | 4.5% | 0.44% | ~ | NA | ~ |
| Bone | 229 | 1.45% | 0.22% | 142 | 1.26% | 0.21% | 86 | 1.40% | 0.18% | 41 | 1.2% | 0.10% | ~ | NA | ~ | ~ | NA | ~ |
| Brain | 398 | 2.52% | 0.38% | 151 | 1.34% | 0.22% | 89 | 1.45% | 0.19% | 92 | 2.7% | 0.22% | ~ | NA | ~ | ~ | NA | ~ |
| Breast | 4,382 | 27.78% | 4.15% | 3,422 | 30.35% | 5.03% | 2,124 | 34.68% | 4.49% | 875 | 26.0% | 2.11% | 210 | 31.4% | 3.11% | 125 | 38.1% | 2.51% |
| Cervix | 282 | 1.79% | 0.27% | 711 | 6.31% | 1.05% | 148 | 2.42% | 0.31% | 143 | 4.3% | 0.34% | 51 | 7.6% | 0.76% | ~ | NA | ~ |
| Colon & Rectum | 1,683 | 10.67% | 1.59% | 604 | 5.36% | 0.89% | 330 | 5.39% | 0.70% | 398 | 11.8% | 0.96% | 43 | 6.4% | 0.64% | 18 | 5.5% | ~ |
| Endocrine System | 1,221 | 7.74% | 1.16% | 104 | 0.92% | 0.15% | 56 | 0.91% | 0.12% | 213 | 6.3% | 0.51% | ~ | NA | ~ | ~ | NA | ~ |
| Endometrium | 788 | 4.99% | 0.75% | 399 | 3.54% | 0.59% | 187 | 3.05% | 0.39% | 268 | 8.0% | 0.65% | 19 | 2.8% | ~ | ~ | NA | ~ |
| Esophagus | 166 | 1.05% | 0.16% | 93 | 0.82% | 0.14% | 52 | 0.85% | 0.11% | 23 | 0.7% | 0.06% | ~ | NA | ~ | ~ | NA | ~ |
| Eye | 92 | 0.58% | 0.09% | 62 | 0.55% | 0.09% | 27 | 0.44% | 0.06% | 13 | 0.4% | ~ | ~ | NA | ~ | ~ | NA | ~ |
| Head & Neck | 1,559 | 9.88% | 1.48% | 296 | 2.63% | 0.44% | 138 | 2.25% | 0.29% | 23 | 0.7% | 0.06% | ~ | NA | ~ | ~ | NA | ~ |
| Kidney | 817 | 5.18% | 0.77% | 399 | 3.54% | 0.59% | 258 | 4.21% | 0.54% | 212 | 6.3% | 0.51% | 31 | 4.6% | 0.46% | 22 | 6.7% | 0.44% |
| Lung | 700 | 4.44% | 0.66% | 389 | 3.45% | 0.57% | 244 | 3.98% | 0.52% | 219 | 6.5% | 0.53% | 25 | 3.7% | 0.37% | ~ | NA | ~ |
| Other Site | NA | NA | ~ | 1,499 | 13.29% | 2.20% | 601 | 9.81% | 1.27% | ~ | NA | ~ | 90 | 13.5% | 1.33% | 42 | 12.8% | 0.84% |
| Ovary | 501 | 3.18% | 0.47% | 284 | 2.52% | 0.42% | 170 | 2.78% | 0.36% | 103 | 3.1% | 0.25% | 25 | 3.7% | 0.37% | ~ | NA | ~ |
| Pancreas | 346 | 2.19% | 0.33% | 94 | 0.83% | 0.14% | 61 | 1.00% | 0.13% | 76 | 2.3% | 0.18% | ~ | NA | ~ | ~ | NA | ~ |
| Prostate | 2,837 | 17.98% | 2.68% | 1,915 | 16.98% | 2.82% | 1,155 | 18.86% | 2.44% | 605 | 18.0% | 1.46% | 114 | 17.0% | 1.69% | 60 | 18.3% | 1.21% |
| Stomach | 174 | 1.10% | 0.16% | 59 | 0.52% | 0.09% | 29 | 0.47% | 0.06% | 51 | 1.5% | 0.12% | ~ | NA | ~ | ~ | NA | ~ |
| Thyroid | 1,068 | 6.77% | 1.01% | 798 | 7.08% | 1.17% | 493 | 8.05% | 1.04% | 182 | 5.4% | 0.44% | 33 | 4.9% | 0.00% | 15 | 4.6% | ~ |
*Skin cancer is excluded from the analysis as it is not differentiated as malignant/non-malignant/melanoma in AoU survey.
** Less than 20 cancers are excluded from analysis and indicated as ~.